1. Home
  2. EVER vs HROW Comparison

EVER vs HROW Comparison

Compare EVER & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EverQuote Inc.

EVER

EverQuote Inc.

N/A

Current Price

$29.10

Market Cap

928.5M

Sector

Technology

ML Signal

N/A

HROW

Harrow Inc.

N/A

Current Price

$30.67

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EVER
HROW
Founded
2008
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
928.5M
1.0B
IPO Year
2018
2008

Fundamental Metrics

Financial Performance
Metric
EVER
HROW
Price
$29.10
$30.67
Analyst Decision
Buy
Strong Buy
Analyst Count
8
9
Target Price
$32.33
★ $62.25
AVG Volume (30 Days)
★ 684.7K
637.4K
Earning Date
11-02-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 198.86
71.43
EPS
★ 1.53
N/A
Revenue
★ $163,349,000.00
N/A
Revenue This Year
$18.77
$28.13
Revenue Next Year
$11.02
$56.02
P/E Ratio
$18.76
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.88
$25.76
52 Week High
$31.20
$54.98

Technical Indicators

Market Signals
Indicator
EVER
HROW
Relative Strength Index (RSI) 63.75 52.98
Support Level $22.38 $28.54
Resistance Level $31.20 $35.32
Average True Range (ATR) 1.57 1.96
MACD -0.06 0.50
Stochastic Oscillator 66.18 59.98

Price Performance

Historical Comparison
EVER
HROW

About EVER EverQuote Inc.

EverQuote Inc operates an online marketplace for insurance shopping, connecting consumers with insurance providers, including carriers and agents. Its marketplace is powered by proprietary data and technology platform that delivers high-intent, pre-validated consumer referrals aligned with insurers underwriting and profitability requirements. The platform provides transparency and campaign management tools, enabling providers to evaluate marketing spend performance and manage return on investment. Consumers can visit insurance provider websites, engage by phone, or submit data to receive quotes. Services are free for consumers, and the company derives revenue principally from consumer inquiries sold as referrals to insurance providers. It derives a majority of revenue from Direct channels.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.

Share on Social Networks: